Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-051733
Filing Date
2025-11-12
Accepted
2025-11-12 17:48:44
Documents
1
Period of Report
2025-11-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1762987721.html 4  
1 FORM 4 wk-form4_1762987721.xml 4 6860
  Complete submission text file 0001628280-25-051733.txt   8264
Mailing Address 30 HUDSON STREET FL 33 JERSEY CITY NJ 07302
Business Address 30 HUDSON STREET FL 33 JERSEY CITY NJ 07302 551-430-6000
Organon & Co. (Issuer) CIK: 0001821825 (see all company filings)

EIN.: 464838035 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 30 HUDSON STREET FLOOR 33 JERSEY CITY NJ 07302
Business Address
Drinane Juliana Papa (Reporting) CIK: 0002096406 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40235 | Film No.: 251474588